Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Yamazaki, Yuu ^a   Matsubara, Tomoyasu ^b   Takahashi, Tetsuya ^a   Kurashige, Takashi ^a   Dohi, Eisuke ^a   Hiji, Masanori ^a,c   Nagano, Yoshito ^a   Yamawaki, Takemori ^a   Matsumoto, Masayasu ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b ASO IIZUKA HOSPITAL   (Japan)

^c Mifukai Viha ra Hananosato Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHARGED MULTIVESICULAR BODY PROTEIN 2B; CHMP2B PROTEIN; SERINE; SMAD2 PROTEIN; SMAD3 PROTEIN; TAU PROTEIN; THREONINE; UBIQUITIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; BRAIN NERVE CELL; CELL GRANULE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; GRANULOVACUOLAR DEGENERATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MULTIPLE SYSTEM ATROPHY WITH PARKINSONISM; MYOTONIC DYSTROPHY; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PICK PRESENILE DEMENTIA; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCORING SYSTEM; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; NEURODEGENERATIVE DISEASES; PHOSPHORYLATION; TAU PROTEINS;

EID: 80455158143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026996     Document Type: Article

References (61)

1. Woodard JS, (1962) Clinicopathologic significance of granulovacuolar degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 21: 85-91.
2. Okamoto K, Hirai S, Iizuka T, Yanagisawa T, Watanabe M, (1991) Reexamination of granulovacuolar degeneration. Acta Neuropathol 82: 340-345.
3. Bondareff W, Wischik CM, Novak M, Roth M, (1991) Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease. Am J Pathol 139: 641-647.
4. Dickson DW, Ksiezak-Reding H, Davies P, Yen SH, (1987) A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration. Acta Neuropathol 73: 254-258.
5. Ikegami K, Kimura T, Katsuragi S, Ono T, Yamamoto H, et al. (1996) Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules. Psychiatry Clin Neurosci 50: 137-140.
6. Mena R, Robitaille Y, Cuello AC, (1992) New patterns of intraneuronal accumulation of the microtubular binding domain of tau in granulovacuolar degeneration. J Geriatr Psychiatry Neurol 5: 132-141.
7. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, et al. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100: 10032-10037.
8. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, et al. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 97: 395-406.
9. Jellinger KA, Stadelmann C, (2000) Mechanisms of cell death in neurodegenerative disorders. J Neural Transm Suppl 59: 95-114.
10. Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, et al. (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 58: 1020-1026.
11. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, et al. (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155: 1459-1466.
12. Su JH, Kesslak JP, Head E, Cotman CW, (2002) Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol 104: 1-6.
13. Ghoshal N, Smiley JF, DeMaggio AJ, Hoekstra MF, Cochran EJ, et al. (1999) A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. Am J Pathol 155: 1163-1172.
14. Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, et al. (2003) Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am J Pathol 163: 1057-1067.
15. Kannanayakal TJ, Tao H, Vandre DD, Kuret J, (2006) Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions. Acta Neuropathol 111: 413-421.
16. Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, et al. (2002) The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol 103: 91-99.
17. Schwab C, DeMaggio AJ, Ghoshal N, Binder LI, Kuret J, et al. (2000) Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol Aging 21: 503-510.
18. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, et al. (2009) The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol 174: 1241-1251.
19. Kadokura A, Yamazaki T, Kakuda S, Makioka K, Lemere CA, et al. (2009) Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration. Neurosci Lett 463: 87-92.
20. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, et al. (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61: 435-445.
21. Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, et al. (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 1184: 284-294.
22. Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, et al. (2008) Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 116: 215-220.
23. Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, et al. (2008) Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70: 1850-1857.
24. Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K, (2009) Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Neuropathology 29: 566-573.
25. Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, et al. (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67: 555-564.
26. Love S, Saitoh T, Quijada S, Cole GM, Terry RD, (1988) Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 47: 393-405.
27. Ghanevati M, Miller CA, (2005) Phospho-beta-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction. J Mol Neurosci 25: 79-94.
28. Holzer M, Gartner U, Stobe A, Hartig W, Gruschka H, et al. (2002) Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol 104: 471-481.
29. Yamazaki Y, Takahashi T, Hiji M, Kurashige T, Izumi Y, et al. (2010) Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus. Neurosci Lett 477: 86-90.
30. Funk KE, Mrak RE, Kuret J, (2010) Granulovacuolar Degeneration Bodies of Alzheimer's Disease Resemble Late-stage Autophagic Organelles. Neuropathol Appl Neurobiol.
31. Lagalwar S, Guillozet-Bongaarts AL, Berry RW, Binder LI, (2006) Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease. J Neuropathol Exp Neurol 65: 455-464.
32. Ball MJ, (1978) Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study. Acta Neuropathol 42: 73-80.
33. Steele JC, Richardson JC, Olszewski J, (1964) Progressive Supranuclear Palsy. A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum with Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia. Arch Neurol 10: 333-359.
34. Eidelberg D, Sotrel A, Joachim C, Selkoe D, Forman A, et al. (1987) Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Brain 110 (Pt 4):: 993-1013.
35. Gibb WR, Luthert PJ, Marsden CD, (1989) Corticobasal degeneration. Brain 112 (Pt 5):: 1171-1192.
36. Towfighi J, (1972) Early Pick's disease. A light and ultrastructural study. Acta Neuropathol 21: 224-231.
37. Filimonenko M, Stuffers S, Raiborg C, Yamamoto A, Malerod L, et al. (2007) Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol 179: 485-500.
38. Chalmers KA, Love S, (2007) Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons. J Neuropathol Exp Neurol 66: 158-167.
39. Xu M, Shibayama H, Kobayashi H, Yamada K, Ishihara R, et al. (1992) Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients-a quantitative study. Acta Neuropathol 85: 1-9.
40. Spillantini MG, Tolnay M, Love S, Goedert M, (1999) Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathol 97: 585-594.
41. Lagalwar S, Berry RW, Binder LI, (2007) Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies. Acta Neuropathol 113: 63-73.
42. Ball MJ, (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol 37: 111-118.
43. Flament S, Delacourte A, Mann DM, (1990) Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome. Brain Res 516: 15-19.
44. Vermersch P, Delacourte A, Javoy-Agid F, Hauw JJ, Agid Y, (1993) Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins. Ann Neurol 33: 445-450.
45. Schmidt ML, Huang R, Martin JA, Henley J, Mawal-Dewan M, et al. (1996) Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau. J Neuropathol Exp Neurol 55: 534-539.
46. Buee Scherrer V, Hof PR, Buee L, Leveugle B, Vermersch P, et al. (1996) Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 91: 351-359.
47. Lieberman AP, Trojanowski JQ, Lee VM, Balin BJ, Ding XS, et al. (1998) Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease. Ann Neurol 43: 259-265.
48. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT, (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42: 631-639.
49. Bondareff W, Mountjoy CQ, Roth M, Hauser DL, (1989) Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol Aging 10: 709-715.
50. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
51. Kiuchi A, Otsuka N, Namba Y, Nakano I, Tomonaga M, (1991) Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol 82: 1-5.
52. Gertz HJ, Xuereb JH, Huppert FA, Brayne C, Kruger H, et al. (1996) The relationship between clinical dementia and neuropathological staging (Braak) in a very elderly community sample. European Archives of Psychiatry and Clinical Neuroscience 246: 132-136.
53. Bronner IF, ter Meulen BC, Azmani A, Severijnen LA, Willemsen R, et al. (2005) Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 128: 2645-2653.
54. Hof PR, Bouras C, Buee L, Delacourte A, Perl DP, et al. (1992) Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol 85: 23-30.
55. Hof PR, Charpiot A, Delacourte A, Buee L, Purohit D, et al. (1992) Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci Lett 139: 10-14.
56. Hof PR, Delacourte A, Bouras C, (1992) Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol 84: 45-51.
57. Arriagada PV, Marzloff K, Hyman BT, (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 42: 1681-1688.
58. Tomlinson BE, Blessed G, Roth M, (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205-242.
59. Molsa PK, Sako E, Paljarvi L, Rinne JO, Rinne UK, (1987) Alzheimer's disease: neuropathological correlates of cognitive and motor disorders. Acta Neurol Scand 75: 376-384.
60. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K, (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112: 389-404.
61. Cohen J, (1988) Statistical power analysis for the behavioral sciences. In: Hillsdale, editors. N.J L. Erlbaum Associates. xxi, 567.